Portfolio Management Execution with Julia Reznick, Teva Pharmaceuticals - SmartOrg webinar

Julia Reznick is the VP of Global Portfolio and Pipeline for Teva Global Specialty Medicine, a division of the Top Ten global pharmaceutical company. In 2010, Teva faced the imminent expiration of patent protection on its flagship product. They looked to portfolio management as the way to focus their development efforts and create sustainable growth to replace that product.

In this webinar, Portfolio Management Evolution, Julia tells how Teva successfully made the transition even as the company undertook a major acquisition. She explains why she describes portfolio management as the “spinal cord” of an organization, coordinating the planning and execution by all of its parts to achieve the organization’s strategic goals. She describes the role SmartOrg®played in Teva’s portfolio management success.
************************************************************
Join 1,000s of executives who rely on ValuePoint for Strategic Portfolio Management insights and for unique perspectives into connecting innovation and finance. Sign up and immediately get our 3 most popular ValuePoints today! https://bit.ly/2M5mL56
************************************************************

About SmartOrg
Founded in 2000 and privately held, SmartOrg's strategic portfolio evaluation platform and associated services align innovation and finance to overcome conflict and drive breakthrough growth. SmartOrg's software is used by companies in a wide range of industries, including oil & gas, pharmaceuticals, engineered materials, consumer products, and agriculture. To learn more about SmartOrg, visit https://smartorg.com/

Видео Portfolio Management Execution with Julia Reznick, Teva Pharmaceuticals - SmartOrg webinar канала SmartOrgInc